Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Carl Hansen , University of British Columbia × Clear Filters

1 results found

Microfluidic Screening Technology for the Discovery of Function-Modifying Antibodies Against Membrane Protein Targets

Antibody (Ab)-based therapeutics are the fastest growing class of drugs, with approximately 60 approved molecules that represent a market of over $80B.

Project completed See Project & Researchers
Grant type
Platform grants
Area of Research
Neurotechnology
Competition
CQDM - Brain Canada - Quantum Leap
Province
British Columbia
Start Date
2017